Back
Reviva Pharmaceuticals Holdings Vs. ePlus Industry Stock Comparison
Sell
28
RVPH
Reviva Pharmaceuticals Holdings
Last Price:
1.21
Seasonality Move:
-14.71%
Sell
27
PLUS
ePlus
Last Price:
80.50
Seasonality Move:
20.86%
Sell
28
Reviva Pharmaceuticals Holdings (RVPH)
is a Sell
Is Reviva Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Reviva Pharmaceuticals Holdings [RVPH] share price is $1.25. The Score for RVPH is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- RVPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
ePlus (PLUS)
is a Sell
Is ePlus a Buy, Sell or Hold?
- The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVPH Stock Price Chart
What is Reviva Pharmaceuticals Holdings's stock price today?
-
The Reviva Pharmaceuticals Holdings share price today is $1.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVPH is experiencing slight selling pressure.
PLUS Stock Price Chart
RVPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 55.84 | Buy |
| Chaikin Money Flow: | -677466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1 - 1.32) | Buy |
| Bollinger Bands (100): | (0.96 - 1.32) | Buy |
PLUS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.37 | Sell |
| Relative Strength Index (14 RSI): | 28.12 | Sell |
| Chaikin Money Flow: | -371573 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (91.15 - 100.85) | Sell |
| Bollinger Bands (100): | (81.19 - 98.29) | Sell |
RVPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.03 | Buy |
| 20-day SMA: | 1.15 | Buy |
| 50-day SMA: | 1.22 | Buy |
| 200-day SMA: | 2.03 | Sell |
| 8-day EMA: | 1.11 | Buy |
| 20-day EMA: | 1.12 | Buy |
| 50-day EMA: | 1.17 | Buy |
| 200-day EMA: | 1.96 | Sell |
PLUS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 93.25 | Sell |
| 20-day SMA: | 94.97 | Sell |
| 50-day SMA: | 95.27 | Sell |
| 200-day SMA: | 83.59 | Sell |
| 8-day EMA: | 92.26 | Sell |
| 20-day EMA: | 94.28 | Sell |
| 50-day EMA: | 94.05 | Sell |
| 200-day EMA: | 84.44 | Sell |
Reviva Pharmaceuticals Holdings Earnings Growth & RVPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.14 per share.
ePlus Earnings Growth & PLUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.
Reviva Pharmaceuticals Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ePlus Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||